Who
Seth H. Z. Fischer
Director
Company insider
Files Form 4 as: Director, Esperion Therapeutics; Director, Milestone Pharmaceuticals; Director, Marinus Pharmaceuticals; Director, Agile Therapeutics; Director, Spectrum Pharmaceuticals; Director, Streamex; Chief Executive Officer, Vivus; Director, Trius Therapeutics.
In numbers
- Trades disclosed
- 94
- Buys
- 1
- Sells
- 3
- Bought
- $19K
- Sold
- $62K
- Companies
- 8
- Companies where not an officer
- 7
- First trade
- 3 Apr 2013
- Last trade
- 13 Jul 2026
- Last filed
- 13 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 13 Jul 2026filed 13 Jul 2026 | Esperion TherapeuticsBiotechnology | SEC FORM 4 Code D | —141,023 | filing |
| 13 Jul 2026filed 13 Jul 2026 | Esperion Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —21,000 | filing |
| 13 Jul 2026filed 13 Jul 2026 | Esperion Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —32,500 | filing |
| 13 Jul 2026filed 13 Jul 2026 | Esperion Therapeuticsoption or derivative | SEC FORM 4 Code D | —21,000 | filing |
| 13 Jul 2026filed 13 Jul 2026 | Esperion Therapeuticsoption or derivative | SEC FORM 4 Code D | —32,500 | filing |
| 13 Jul 2026filed 13 Jul 2026 | Esperion Therapeuticsoption or derivative | SEC FORM 4 Code D | —44,000 | filing |
| 13 Jul 2026filed 13 Jul 2026 | Esperion Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —44,000 | filing |
| 13 Jul 2026filed 13 Jul 2026 | Esperion Therapeutics | SEC FORM 4 Code D | —141,023 | filing |
| 10 Jun 2026filed 12 Jun 2026 | MIST Milestone Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —77,000 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | MIST Milestone Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —77,000 at $0.00 | filing |
| 28 May 2026filed 1 Jun 2026 | Esperion TherapeuticsBiotechnology | SEC FORM 4 Code A | —79,873 at $0.00 | filing |
| 28 May 2026filed 1 Jun 2026 | Esperion Therapeutics | SEC FORM 4 Code A | —79,873 at $0.00 | filing |
| 10 Jun 2025filed 12 Jun 2025 | MIST Milestone Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 29 May 2025filed 2 Jun 2025 | Esperion Therapeuticsoption or derivative | SEC FORM 4 Code A | —44,000 at $0.00 | filing |
| 29 May 2025filed 2 Jun 2025 | Esperion Therapeutics | SEC FORM 4 Code A | —33,000 at $0.00 | filing |
| 11 Feb 2025filed 11 Feb 2025 | Marinus Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —10,450 at $0.00 | filing |
| 11 Feb 2025filed 11 Feb 2025 | Marinus Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —20,900 at $0.00 | filing |
| 11 Feb 2025filed 11 Feb 2025 | Marinus Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —16,200 at $0.00 | filing |
| 11 Feb 2025filed 11 Feb 2025 | Marinus Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —12,375 at $0.00 | filing |
| 11 Feb 2025filed 11 Feb 2025 | Marinus Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —16,500 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
Related people
Nobody else traded the same names lately.